Use of LMWH (Low molecular Weight Heparins ) in treating Venous Thromboembolism (VTE)

The risk of having Venous Thromboembolism (VTE) in cancer patients is high due to poor prognosis. VTE as such is an independent risk factor for cancer, and there is an increase in incidence by 7-fold to develop VTE in cancer patients. It is estimated that around 15-20% of patients with Pulmonary Embolism (PE) or Deep-Vein…

Read More

Hemophilia

X- linked recessive hemorrhagic disease due to the mutation in the F8 gene ( Hemophilia A ), and F9 gene is responsible for Hemophilia B. Since it is an X linked disorder males are clinically more affected than females. Males have XY chromosome, so if the X chromosome is affected the Y isn’t able to…

Read More